Tickerplace logo

Tickerplace

Chimeric Therapeutics Limited logo

CHMChimeric Therapeutics Limited

CHM Stock Price, Valuation & Chart | Chimeric Therapeutics Limited

Compare
$0.010+0.00 (+0.00%)

At close · 02 Sept 2026, 06:10 am

Sector: HealthcareCHM intrinsic valueCHM calculated fair value vs priceWebsite
OverviewFinancialsDividendsRatios

CHM Historical price chart

CHM Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization492.52K
PE Ratio-0.01
EPS-0.95
Trading Volume17.55K
Today's High/Low0.01/0.01
Dividend Yield0.00
52 Week High/Low0.4/0.01
Shares Outstanding41.04M
CHM Financial Statement

CHM Analyst ratings

Buy

Strong buy
0
Buy
0
Hold
0
Sell
0
Strong sell
0

Based on 0 analysts giving stock ratings to CHM in the past 3 months.

CHM Analysis & performance metrics

CHM Company profile

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM…

CHM Management team

Management
Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD
Founder & Executive Chairman
Jason B. Litten M.D.CTO
Chief Technology Officer
Stephanie H. Astrow MBA, Ph.D.
Chief Scientific Officer
Total 3 executives

CHM Frequently asked questions

What is Chimeric Therapeutics Limited (CHM) Stock Price?

Current stock price of Chimeric Therapeutics Limited (CHM) stock is $0.010. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Chimeric Therapeutics Limited (CHM) stock is 17.55K.

Last updated at 02 Sept 2026, 06:10 am.

Why is the Chimeric Therapeutics Limited (CHM) stock price going up or down today?

The stock price of Chimeric Therapeutics Limited (CHM) can change with earnings, company news, and overall market sentiment. Chimeric Therapeutics Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Chimeric Therapeutics Limited stock expensive at its current price?

Whether Chimeric Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CHM on this page is -0.01. EPS on this page is -0.95. Compare those figures with peers and growth expectations before deciding if the current Chimeric Therapeutics Limited price is justified.

How has the stock price of Chimeric Therapeutics Limited (CHM) performed historically?

Historical performance for Chimeric Therapeutics Limited (CHM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CHM reacted to past earnings and market events.

Should I buy Chimeric Therapeutics Limited (CHM) stock, at this price?

Buying Chimeric Therapeutics Limited (CHM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.